Suppr超能文献

通过转染P-糖蛋白肝脏特异性姐妹基因介导的紫杉醇耐药性。

Taxol resistance mediated by transfection of the liver-specific sister gene of P-glycoprotein.

作者信息

Childs S, Yeh R L, Hui D, Ling V

机构信息

BC Cancer Research Center, BC Cancer Agency, University of British Columbia, Vancouver, Canada.

出版信息

Cancer Res. 1998 Sep 15;58(18):4160-7.

PMID:9751629
Abstract

The sister gene of P-glycoprotein (Spgp) is a liver-specific ATP-binding cassette protein highly related to the P-glycoprotein (Pgp) family (S. Childs et al, Cancer Res., 55: 2029-2034, 1995). Spgp appears to be related to the Pgp family by an ancient duplication occurring before the division of fish and mammals. P-Glycoproteins have diverse functions including broad specificity multidrug resistance in cell lines and tumors, detoxification of tissues such as the intestine and blood-brain barrier, and phosphatidylcholine transport in liver. Spgp is a Mr approximately 170,000 glycosylated plasma membrane protein localized to the canalicular surface of hepatocytes in the rat liver. The full-length cDNA of Spgp was isolated from rat, and its expression was characterized in situ and in transfected cells. The expression of Spgp correlates with the differentiation of hepatocytes and is seen only in late liver development. It is not observed in hepatoma cell lines. The physiological function of Spgp in liver is unknown, but it maps to 2q31 in humans, in the vicinity of liver transport disorders for bile acids and cholesterol. Spgp may therefore be involved in some aspect of bile acid or cholesterol metabolism. Spgp transfectants have a low level resistance to Taxol but not to other drugs that form part of the multidrug resistance phenotype. This resistance is reversible by the Pgp-reversing agents cyclosporin A, PSC833, and verapamil, suggesting a conservation in some functions of Pgps across large evolutionary distance.

摘要

P-糖蛋白的姐妹基因(Spgp)是一种肝脏特异性ATP结合盒蛋白,与P-糖蛋白(Pgp)家族高度相关(S. 蔡尔兹等人,《癌症研究》,55: 2029 - 2034,1995年)。Spgp似乎通过鱼类和哺乳动物分化之前发生的一次古老基因复制与Pgp家族相关。P-糖蛋白具有多种功能,包括细胞系和肿瘤中的广泛特异性多药耐药性、肠道和血脑屏障等组织的解毒作用以及肝脏中的磷脂酰胆碱转运。Spgp是一种分子量约为170,000的糖基化质膜蛋白,定位于大鼠肝脏肝细胞的胆小管表面。Spgp的全长cDNA从大鼠中分离出来,其表达在原位和转染细胞中进行了表征。Spgp的表达与肝细胞的分化相关,仅在肝脏发育后期可见。在肝癌细胞系中未观察到。Spgp在肝脏中的生理功能尚不清楚,但它在人类中定位于2q31,靠近胆汁酸和胆固醇的肝脏转运障碍区域。因此,Spgp可能参与胆汁酸或胆固醇代谢的某些方面。Spgp转染细胞对紫杉醇有低水平抗性,但对构成多药耐药表型一部分的其他药物没有抗性。这种抗性可被Pgp逆转剂环孢素A、PSC833和维拉帕米逆转,表明Pgp的某些功能在较大进化距离上具有保守性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验